advancing innovation to save lives

GHTC director profiled in Impact Magazine

GHTC Director Jamie Bay Nishi was profiled in an article by Impact Magazine, covering challenges facing global health research and development (R&D) and the coalition's efforts to better inform policy makers.
View

Return on innovation

A new report from GHTC examines the impact of US government investment in global health R&D at home and abroad, from delivering lifesaving tools for the world’s most vulnerable people to generating economic and security returns for the United States.
 
Learn More

Jhpiego

Jhpiego (pronounced "ja-pie-go") is an international, non-profit health organization affiliated with Johns Hopkins University. For 42 years, Jhpiego has empowered front-line health workers by designing and implementing effective, low-cost, hands-on solutions to strengthen the delivery of health care services for women and their families.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Gabe Bienczycki
Contagion interviews GHTC Director on creation of Essential Diagnostics List

Contagion interviewed GHTC Director Jamie Bay Nishi regarding the World Health Organization's creation of the Essential Diagnostics List (EDL). The article focuses on the benefits of the EDL and how countries can use it to assess their burdens of disease, saving lives and money in the process.

View
GHTC submits input on TB Ministerial Meeting Zero Draft

GHTC submitted input to the online consultation on the Zero Draft of the Declaration proposed for the Global Ministerial Conference on Ending Tuberculosis in the Sustainable Development Era expressing strong support for the draft language and calling on drafters to ensure that future versions retain strong support for innovation and R&D as core components of combating tuberculosis (TB).

PDF
View All News & Events

Member Event

PATH/Eric Becker
Results International Conference 2017
Results
Learn More

Community Event

PATH/Matthew Dakin
9th IAS Conference on HIV Science
IAS
Learn More
View All Events
PATH/Satvir Malhotra
Research Roundup: Vaccines as a tool to cure and protect, and what went right in the DRC Ebola outbreak

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Mike Wang
Research Roundup: Malaria research funding uneven and inequitable, Europe's plan to combat AMR, and unverified malaria medicines on the global market

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide